Cargando…
Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease
Parkinson disease (PD) is a neurodegenerative disease mainly characterized by the loss of nigral dopaminergic neurons in the substantia nigra pars compacta. Patients suffering from PD develop severe motor dysfunctions and a myriad of non-motor symptoms. The treatment mainly consists of increasing ce...
Autores principales: | Holanda, Victor A. D., Didonet, Julia J., Costa, Manara B. B., do Nascimento Rangel, Adriano H., da Silva, Edilson D., Gavioli, Elaine C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401573/ https://www.ncbi.nlm.nih.gov/pubmed/34451872 http://dx.doi.org/10.3390/ph14080775 |
Ejemplares similares
-
Blockade of nociceptin/orphanin FQ signaling facilitates an active copying strategy due to acute and repeated stressful stimuli in mice
por: Holanda, Victor A.D., et al.
Publicado: (2020) -
The Emerging Role of Neuropeptides in Parkinson’s Disease
por: Zheng, Yanan, et al.
Publicado: (2021) -
Demystifying the Neuroprotective Role of Neuropeptides in Parkinson’s Disease: A Newfangled and Eloquent Therapeutic Perspective
por: Behl, Tapan, et al.
Publicado: (2022) -
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
por: Hanrieder, Jörg, et al.
Publicado: (2012) -
Influence of pain-relieving therapies on inflammation and the expression of proinflammatory neuropeptides after dental bleaching treatment
por: da Silva, Livia Maria Alves Valentim, et al.
Publicado: (2020)